Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast

被引:34
|
作者
Berner, HS [1 ]
Nesland, JM [1 ]
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
关键词
infiltrating lobular carcinoma; immunohistochemistry; CD44;
D O I
10.1023/A:1006417412046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of CD44 has been shown to correlate with the progression and prognosis of some malignant tumors. The aim of this study was to evaluate the expression of CD44 isoforms in infiltrating lobular carcinomas and analyse their potential as prognostic indicators. A panel of 39 tumors were examined for their expression of membranous and cytoplasmic CD44s, v3, v5, v6, v7 and v3-10 in the infiltrating cells, by immunohistochemical staining. The protein positive tumors showed membranous and/or cytoplasmic staining with all antibodies used except for CD44v7, which only displayed cytoplasmic staining. Cytoplasmic expression of CD44v3 (P = 0.014) and membranous expression of v6 (P = 0.039) were significantly associated with alveolar, classical/alveolar carcinomas and mucinous/alveolar carcinomas. Furthermore, in alveolar, classical/alveolar and mucinous/alveolar carcinomas, cytoplasmic staining of CD44v5 was correlated with lymph node negative patients (P = 0.048), whereas membranous v5 was correlated with lymph positive patients (P = 0.048). In classical, classical/trabecular and trabecular carcinomas expression of membranous CD44s was significantly correlated with lymph node status (P = 0.042).
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [21] INFILTRATING LOBULAR CARCINOMA OF BREAST
    ASHIKARI, R
    HUVOS, AG
    URBAN, JA
    ROBBINS, GF
    CANCER, 1973, 31 (01) : 110 - 116
  • [22] INFILTRATING LOBULAR CARCINOMA OF THE BREAST
    DIXON, JM
    ANDERSON, TJ
    PAGE, DL
    LEE, D
    DUFFY, SW
    HISTOPATHOLOGY, 1982, 6 (02) : 149 - 161
  • [23] Cytosol concentrations of CD44 isoforms in breast cancer tissue
    Hefler, L
    Tempfer, C
    Heusler, G
    Kucera, E
    Mayerhofer, K
    Zeillinger, R
    Reinthaller, A
    Kainz, C
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (05) : 541 - 545
  • [24] Hyaluronidate receptor CD44 and isoforms in human breast cancer
    Munstedt, K
    Hinrichs, B
    Luig, H
    Mussmann, J
    Gunthert, U
    Franke, FE
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 672 - 672
  • [25] Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones
    Dehmel, A
    Becker, M
    Lemm, M
    Fichtner, I
    ANTICANCER RESEARCH, 1999, 19 (3A) : 1977 - 1987
  • [26] Immunohistochemical Expression of CD44 and CD24 in Ductal Carcinoma In Situ of the Breast
    Kang, G.
    Brown, J. P.
    Gillett, C.
    Pinder, S. E.
    JOURNAL OF PATHOLOGY, 2012, 226 : S12 - S12
  • [27] Histiocytoid breast carcinoma: Solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant
    Fujiwara, M
    Horiguchi, M
    Mori, S
    Yokoyama, K
    Horiguchi, H
    Fukazawa, M
    Fujiwara, H
    Yano, Y
    Satoh, H
    Kamma, H
    PATHOLOGY INTERNATIONAL, 2005, 55 (06) : 353 - 359
  • [28] Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma
    Sagawa, K.
    Uwa, N.
    Daimon, T.
    Sakagami, M.
    Tsujimura, T.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (09): : 843 - 849
  • [29] Expression of CD44 isoforms in human renal cell carcinomas
    Heider, KH
    Ratschek, M
    Zatloukal, K
    Adolf, GR
    VIRCHOWS ARCHIV, 1996, 428 (4-5) : 267 - 273
  • [30] Expression of CD44 and its isoforms in inflammatory skin diseases
    Kaya, G
    Tchérémissinoff, L
    Augsburger, E
    Saurat, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 439 - 439